(Q38697221)

5 September 2017

Role of MicroRNAs in NAFLD/NASH. (English)

1 reference

5 September 2017

1 reference

Gyongyi Szabo

1

1 reference

PubMed ID

26769057

5 September 2017

Timea Csak

series ordinal

2

1 reference

5 September 2017

14 January 2016

1 reference

Digestive Diseases and Sciences

5 September 2017

1 reference

5 September 2017

61

1 reference

5 September 2017

5

1 reference

5 September 2017

1314-1324

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-015-4002-4

5 September 2017

0 references

cites work

The functions of animal microRNAs

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA Processing and Human Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Differential microRNA response to a high-cholesterol, high-fat diet in livers of low and high LDL-C baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA expression profile in Lieber-DeCarli diet-induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Circulating RNA molecules as biomarkers in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Characterization of extracellular circulating microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

The microRNA spectrum in 12 body fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Biodistribution and function of extracellular miRNA-155 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA regulatory networks in human adipose tissue and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Application of microRNAs in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

A concise review of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Differential expression of microRNAs in mouse liver under aberrant energy metabolic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

LNA-mediated microRNA silencing in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

miR-122--a key factor and therapeutic target in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Hepatitis C virus and human miR-122: insights from the bench to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs, the immune system and rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

The miR-34 family in cancer and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Obstructive sleep apnea syndrome and fatty liver: association or causal link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Antitumor function of microRNA-122 against hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Regulation of Adipocyte Differentiation via MicroRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Adipose tissue microRNAs as regulators of CCL2 production in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs regulated by adiponectin as novel targets for controlling adipose tissue inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

The gut microbiota shapes intestinal immune responses during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

The intestinal microbiota in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

The Gut Microbiota and Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Enhanced susceptibility to Citrobacter rodentium infection in microRNA-155-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

TGF-β conditions intestinal T cells to express increased levels of miR-155, associated with down-regulation of IL-2 and itk mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Review of hyperuricemia as new marker for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Asthma and metabolic syndrome: Current knowledge and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

A comprehensive review of metabolic syndrome affecting erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Non-alcoholic fatty liver disease and psoriasis: So far, so near

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Metabolic syndrome and chronic kidney disease: Current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Obesity modulation - the role in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA regulation of allergic inflammation and asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs in lung diseases: Recent findings and their pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs in normal and psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNAs in kidney physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Inhibition of sterile danger signals, uric acid and ATP, prevents inflammasome activation and protects from alcoholic steatohepatitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Uric acid as a danger signal in gout and its comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Inflammasome activation and function in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Sugar, uric acid, and the etiology of diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Role of miR-146a in regulation of the acute inflammatory response to monosodium urate crystals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

High Concentrations of Uric Acid Inhibit Endothelial Cell Migration via miR-663 Which Regulates Phosphatase and Tensin Homolog by Targeting Transforming Growth Factor-β1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

Hepatic angiogenesis and fibrosis are common features in morbidly obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-015-4002-4

MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis

21 January 2018

1 reference

12 December 2020

A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation

1 reference

12 December 2020

1 reference

12 December 2020

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

1 reference

12 December 2020

Hypothalamic miRNAs: emerging roles in energy balance control

1 reference

12 December 2020

MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway

1 reference

12 December 2020

Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetes

1 reference

12 December 2020

Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk

1 reference

12 December 2020

MicroRNAs and cardiovascular diseases

1 reference

12 December 2020

microRNAs as a new mechanism regulating adipose tissue inflammation in obesity and as a novel therapeutic strategy in the metabolic syndrome

1 reference

12 December 2020

miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR

1 reference

12 December 2020

Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease

1 reference

12 December 2020

Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice

1 reference

12 December 2020

MicroRNA expression in human omental and subcutaneous adipose tissue

1 reference

12 December 2020

Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet

1 reference

12 December 2020

Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis

1 reference

12 December 2020

Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.

1 reference

12 December 2020

High concentrations of uric acid inhibit angiogenesis via regulation of the Krüppel-like factor 2-vascular endothelial growth factor-A axis by miR-92a

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression

1 reference

12 December 2020

Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice

1 reference

12 December 2020

Progress and challenge of microRNA research in immunity

1 reference

12 December 2020

Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation

1 reference

12 December 2020

Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications

1 reference

12 December 2020

MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation

1 reference

12 December 2020

MicroRNAs and the regulation of intestinal homeostasis

1 reference

12 December 2020

MicroRNA regulation of intestinal epithelial tight junction permeability

1 reference

12 December 2020

10.1007/S10620-015-4002-4

Identifiers

DOI

1 reference

PubMed ID

26769057

Dimensions Publication ID

5 September 2017

0 references

1 reference

PubMed ID

26769057